All filters
Abstracts
Cost-Effectiveness of DTG/3TC for human immunodeficiency virus (HIV-1) infection treatment in Taiwan
Ou H.
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in treatment experienced patients -Asian Real-world Experience
H. Tsai
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Real-world effectiveness, safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF} in routine clinical practice in people living with HIV (PLWH}, China
T. Yu
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Collaborative care model to facilitate integration of mental healthcare into HIV treatment and prevention services for adolescents and young adults in Bangkok, Thailand
W. Songtaweesin
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Prevalence of Hypogonadism Among People Living with HIV in Taiwan
K. Lin
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Healthcare Transition Outcomes in Adolescents and Young Adults Living with Perinatal HIV in Thailand
L. Aurpibul
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Mortality after loss to follow-up - a linkage study of people living with HIV in Thailand and Malaysia
A. Jiamsakul
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Impact of COVID-19 pandemic on HIV care delivery and access in Asia
T. Wong
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Impact of the COVID-19 Pandemic on HIV Services in Taiwan: Results from a Cross-sectional Online Survey
W. Liu
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
The epidemiological impact of Key Population-Led PrEP delivery on the Thai HIV epidemic among MSM: a modelling study
L. Versteegh
Presented at:
APACC 2021
Abstracts
HIV Integrated Care Unit for Allied Health Services (The HERCULES Project) in a community-based organization, Malaysia
C. Chang
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
A Cross-sectional Study Examining Sexual Health and Health seeking Behavior using LINE survey across Japan
H. Hoshino
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Five-year results of preventive drug administration before exposure to HIV in outpatients
N. Sun
Presented at:
APACC 2021
Abstracts
Amphetamine-type stimulant use is common and associated with HIV infection among MSM and TGW in Bangkok, Thailand
D. Colby
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Pediatric disclosure of HIV status and effect on mortality and LTFU among children and adolescents living with HIV in Asia
J. Sornillo,
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Psychosocial Risk Factors and Cognitive Decline in People Living with HIV: Results from the Malaysian HIV and Aging (MHIVA) Study
M. Neelamegam
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Self-sampled specimens demonstrate comparable sensitivity and specificity to clinician-sampled specimens for HPV detection among MSM in China
Y. Lu
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfected Patients Through 96 Weeks
Y Huang
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Clinical case presentation: A preliminary profile of common co-morbidities and risk practices in a sample of HIV/HCV co-infected patients in Puerto Rico
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically suppressed HIV-1 infected adult subjects harboring the NRTI resistance mutation M184V and/or M184I (GS-US
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Implementation science for HIV prevention using an eHealth program for Spanish-speaking sexual minorities groups in Puerto Rico
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
High prevalence of hepatitis B virus infection among chronic kidney disease patients
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Time to treatment disfavors patients living with HIV/HCV co-infection
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Prevalence of alcohol and substance use in a sample of patients living with HIV/HCV co-infection who are in routine clinical care receiving antiretroviral therapy
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019